Skip to content
TirzepatideReport
Providers

Tracked provider

MEDVi tirzepatide review

A brand-name Zepbound path with named pharmacy partners — and no published medication price at all.

This is a tracked entry: the facts below are what MEDVi publishes about itself, recorded and re-checked as part of the board we maintain (last checked 2026-07-10). Our hand-written reviews go deeper on the programs people ask about most. Prices change — confirm on MEDVi's own site before you pay.

What it costs

Tirzepatide
Pricing varies — MEDVi publishes a $99/month membership for its brand Zepbound path and states the medication cost is charged on top, without publishing it. Its compounded tirzepatide is no longer listed on the site
What is dispensed
Brand-name Zepbound (membership plus separately billed medication); compounded tirzepatide no longer listed
Who compounds it
Network

How the program works

A telehealth weight-loss platform offering compounded GLP-1 injections and tablets alongside brand-name Wegovy and Zepbound, with treatment delivered by OpenLoop Health clinicians and CareGLP affiliated practices. Its genuine strength is supply-chain transparency: it names four US pharmacy partners — Triad Rx, Precision Medicine, RedRock Pharmacy and Beaker Pharmacy & Compounding — where most of this board names none. On tirzepatide specifically the picture has narrowed: compounded tirzepatide has come off the site entirely, and what remains is a brand Zepbound route priced as a $99 membership plus an undisclosed drug cost.

What we like

  • Names four US pharmacy partners — Triad Rx, Precision Medicine, RedRock Pharmacy and Beaker Pharmacy & Compounding
  • Both compounded and brand-name (Wegovy, Zepbound) GLP-1 options on one platform
  • Clinical oversight through the OpenLoop Health provider network and CareGLP affiliated practices
  • Oral tablet and injectable formats offered on the semaglutide side

The caveats

  • No tirzepatide medication price is published at all — the $99 is a membership, and the drug is billed on top of it
  • Compounded tirzepatide is no longer listed anywhere on the site; treat it as discontinued
  • Not available in Mississippi or North Dakota, and five more states require a synchronous visit before prescribing
  • Alabama and California patients can receive injectables only, not tablets
  • No LegitScript or PCAB certification disclosed

Ready to look at MEDVi directly? The link below is tracked so we can see it worked; it goes to their own site.

Visit MEDVi

Advertising disclosure — some, not all, of the providers ranked here are partners, and we may earn a commission at no additional cost to you. The prices and facts we report come from each provider's own published program. Full disclosure.

Other tirzepatide programs we track

← Every provider review